Back

Assessing molecular gene by treatment interactions using a population of neural progenitors exposed to valproic acid and lithium

Valone, J. M.; Le, B. D.; Matoba, N.; Mory, J. T.; Wolter, J. M.; Love, M. I.; Stein, J. L.

2025-09-14 genetic and genomic medicine
10.1101/2025.09.12.25335653 medRxiv
Show abstract

Gene by treatment (GxT) interactions likely contribute to variability in clinical response, but are difficult to identify in population studies. Here, we applied psychiatric and neurological disorder treatments to a genotyped population of human neural progenitors (n=83 donors) and measured molecular responses on chromatin accessibility and gene expression. Gene regulatory responses to valproic acid (VPA), which is also a prenatal risk factor for autism, and lithium were highly enriched in genetic risk for psychiatric disorders, demonstrating the convergence of environmental and genetic factors. Genetic variation impacted molecular response to these drugs at over 1,000 loci, a subset of which modulated the impacts of psychiatric disorder risk variants. Finally, transcriptome-wide association revealed enzymes involved with folate metabolism during VPA exposure impact cognitive ability, a pathway previously shown to alleviate the negative impacts of this exposure. The "GxT in a dish" approach identified a validated treatment pathway, supporting its broad utility.

Published in Molecular Psychiatry (predicted rank #5) · training set

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.